Vir Biotechnology (VIR) Enterprise Value Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Vir Biotechnology | 1.33 Bn | 1.33 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -65.48% |
| Dec 31, 2025 | 39.94% |
| Sep 30, 2025 | -87.94% |
| Jun 30, 2025 | 80.96% |
| Mar 31, 2025 | 71.53% |
| Dec 31, 2024 | -205.23% |
| Sep 30, 2024 | 92.37% |
| Jun 30, 2024 | 37.47% |
| Mar 31, 2024 | 29.56% |
| Dec 31, 2023 | 89.39% |
| Sep 30, 2023 | 46.34% |
| Jun 30, 2023 | -174.84% |
| Mar 31, 2023 | -16.94% |
| Dec 31, 2022 | -949.78% |
| Sep 30, 2022 | -201.74% |
| Jun 30, 2022 | -632.36% |
| Mar 31, 2022 | -65.37% |
| Dec 31, 2021 | 26.76% |
| Sep 30, 2021 | -106.21% |
| Jun 30, 2021 | 52.45% |
| Mar 31, 2021 | -106.13% |
| Dec 31, 2020 | -9.99% |
| Sep 30, 2020 | -16.62% |
| Jun 30, 2020 | -137.52% |
| Mar 31, 2020 | -449.43% |
| Dec 31, 2019 | -184.72% |
| Sep 30, 2019 | -571.72% |